|

Assessment of a Quantra-guided Transfusion Algorithm in Liver Transplantation

RECRUITINGN/ASponsored by University Hospital, Toulouse
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital, Toulouse
Started2025-03-08
Est. completion2027-03
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06749405

Summary

Liver transplantation carries a substantial risk of bleeding, making precise haemostasis control essential, although assessing coagulation remains challenging. Quantra, a bedside viscoelastic testing device using sonorheometric methods, offers an innovative approach to guiding haemostatic management during surgery. The study aims to determine whether a Quantra-guided transfusion can reduce transfusion and bleeding during liver transplantation when compared to a conventional transfusion approach.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients aged 18 years or older
* Patient with ESLD undergoing liver transplantation
* Individuals affiliated with or beneficiaries of a social security scheme
* Free and informed written consent obtained in writing from the patient, or where applicable from the trusted person/family member/close relative

Non-inclusion Criteria:

* Multi-organ transplantation
* Congenital haemostasis disorder (such as haemophilia)
* Patient under juridical protection (persons deprived of liberty or under curatorship or guardianship or safeguard of justice)
* Pregnant or breast-feeding woman
* Patient already enrolled in another interventional study with primary or secondary objective of reducing perioperative bleeding or transfusion

Conditions2

Liver DiseaseLiver Transplantation

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.